Showing results (21-30 of 91) with videos related to
Sort By:
Pageof 10
Haematologica|September 13, 2005
Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow TransplantationGiovanni Barosi, Angelo Carella, Mario Lazzarino, et al.Biology|March 6, 2021
HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two CasesStefano Fiori, Elisabetta Todisco, Safaa Ramadan, et al.Medical Oncology (Northwood, London, England)|October 5, 2006
High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remissionIgnazio Majolino, Marco Ladetto, Anna Locasciulli, et al.Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|October 6, 2010
[Lymphomatous renal involvement]Luca Besso, Alessandro Domenico Quercia, Germana Daidola, et al.La Radiologia Medica|April 20, 2017
Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphomaAnnalisa Balbo-Mussetto, Chiara Saviolo, Alberto Fornari, et al.Experimental Hematology|April 2, 2013
Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapyMarco Ruella, Silvia Salmoiraghi, Alessandra Risso, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Concurrent G-CSF and GM-CSF administration for the induction of bone marrow-derived cell mobilization in patients with acute myocardial infarction: a pilot study evaluating feasibility, safety and efficacySebastiano Marra, Paolo Scacciatella, Tullio Usmiani, et al.Journal of Hepatology|April 26, 2006
Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver diseaseSilvia Gaia, Antonina Smedile, Paola Omedè, et al.Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, et al.Mediterranean Journal of Hematology and Infectious Diseases|March 22, 2021
Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's LymphomasSafaa Ramadan, Giusy Ceparano, Alessandro Cignetti, et al.Pageof 10